Gardasil 9 syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FJLCA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,034
Award facts
- Contract value 100% obligated
- $11,033.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $11,033.76 to DMS Pharmaceutical Group Inc. for the supply of GARDASIL 9 syringes (0.5ML) with an ultimate completion date of August 19, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The award represents a delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500 million and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for military healthcare facilities worldwide.
GARDASIL 9 is a vaccine used for the prevention of human papillomavirus-related cancers and diseases, making this delivery order part of DLA's broader pharmaceutical supply chain supporting Department of Defense healthcare operations. As a established federal contractor since 2001, DMS Pharmaceutical Group has demonstrated capability in delivering specialized pharmaceutical products, including vaccines, biologics, and other critical medical supplies to military health facilities. The firm fixed-price structure provides cost certainty for this specific vaccine procurement requirement within the framework of the larger IDC vehicle.
Quick answers
Who was awarded contract SPE2DB25FJLCA?
SPE2DB25FJLCA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FJLCA worth?
The government has obligated $11,034 on SPE2DB25FJLCA.
Is contract SPE2DB25FJLCA an order under another contract?
Yes. SPE2DB25FJLCA is a delivery order under SPE2DB24D9802, an indefinite delivery contract.
Was contract SPE2DB25FJLCA competed?
The extent of competition for SPE2DB25FJLCA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award